Predictions
Precision BioSciences Inc
Start price
Target price
Perf. (%)
€5.05
14.08.20
14.08.20
-
25.08.20
25.08.20
-3.76%
25.08.20
25.08.20
Lexicon Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1.53
13.08.20
13.08.20
-
24.08.20
24.08.20
-3.82%
24.08.20
24.08.20
Qualigen Therapeutics Inc.
Start price
Target price
Perf. (%)
€47.00
13.08.20
13.08.20
-
19.08.20
19.08.20
-6.81%
19.08.20
19.08.20
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€98.39
13.08.20
13.08.20
-
19.08.20
19.08.20
-20.34%
19.08.20
19.08.20
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.94
13.08.20
13.08.20
-
14.08.20
14.08.20
-0.37%
14.08.20
14.08.20
GW Pharmaceuticals plc ADR
Start price
Target price
Perf. (%)
€91.50
13.08.20
13.08.20
-
14.08.20
14.08.20
-2.19%
14.08.20
14.08.20
Adverum Biotechnologies Inc.
Start price
Target price
Perf. (%)
€11.10
13.08.20
13.08.20
-
26.08.20
26.08.20
-5.41%
26.08.20
26.08.20
Palatin Technologies Inc.
Start price
Target price
Perf. (%)
€11.50
13.08.20
13.08.20
-
28.08.20
28.08.20
1.07%
28.08.20
28.08.20
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€4.00
13.08.20
13.08.20
-
14.08.20
14.08.20
-3.65%
14.08.20
14.08.20
India Globalization Capital
Start price
Target price
Perf. (%)
€1.91
13.08.20
13.08.20
-
14.08.20
14.08.20
-20.22%
14.08.20
14.08.20
Purple Biotech Ltd. ADR
Start price
Target price
Perf. (%)
€4.90
13.08.20
13.08.20
-
14.08.20
14.08.20
-7.76%
14.08.20
14.08.20
Onconova Therapeutics Inc
Start price
Target price
Perf. (%)
€13.07
13.08.20
13.08.20
-
14.08.20
14.08.20
-8.13%
14.08.20
14.08.20
Dicerna Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€16.00
13.08.20
13.08.20
-
26.08.20
26.08.20
-3.13%
26.08.20
26.08.20
Editas Medicine Inc
Start price
Target price
Perf. (%)
€29.98
13.08.20
13.08.20
€34.30
13.10.20
13.10.20
-7.20%
13.10.20
13.10.20
Riot Blockchain Inc.
Start price
Target price
Perf. (%)
€2.66
13.08.20
13.08.20
€25.00
04.11.21
04.11.21
975.97%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Future proof or reliable business model